Real-World Cost of Nasal Polyps Surgery and Risk of Major Complications in the United States: A Descriptive Retrospective Database Analysis

被引:2
|
作者
Ge, Wenzhen [1 ]
Wang, Degang [1 ]
Chuang, Chien-Chia [2 ]
Li, Yongtao [3 ]
Rout, Raj [4 ]
Siddiqui, Shahid [1 ]
Kamat, Siddhesh [1 ]
机构
[1] Regeneron, Hlth Econ & Outcomes Res, Med Affairs, Tarrytown, NY 10591 USA
[2] Sanofi, Global Hlth Econ & Value Assessment, Cambridge, MA USA
[3] Sanofi, Global Med Affairs, Bridgewater, NJ USA
[4] Sanofi, Global Med Affairs, Reading, England
来源
关键词
chronic rhinosinusitis with nasal polyps; nasal polyp surgery; real-world; complications; costs; ENDOSCOPIC SINUS SURGERY; CHRONIC RHINOSINUSITIS;
D O I
10.2147/CEOR.S380411
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Endoscopic nasal polyp (NP) surgery is a treatment option for patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Previous studies report NP surgery costs of $8000-13,000 and risk of major complications of NP surgery of similar to 0.1-1%. Limited contemporary data for costs and complications associated with NP surgery in US clinical practice are available. Methods: IQVIA PharMetrics Plus claims data were used to identify patients with NP surgery in 2019 with >= 3 years continuous baseline health-plan enrollment prior to index date (date of first eligible NP surgery) and >= 30 days continuous enrollment after index (follow-up). In this descriptive analysis, total costs of NP surgery were estimated as all medical costs on the index date (or during the entire hospital stay for patients who received surgery in the inpatient setting). Total medical costs (all-cause) were estimated for all medical services occurring from the index date to the index date +9 or +29 days (10-day and 30-day). Major complication was defined as cerebrospinal fluid (CSF) leak, orbital injury, or major hemorrhage within 30 days of index. Results: Of 6311 patients, median age was 46 years (interquartile range: 34-56); 59.7% were male; 88.2% had no NP surgery in the prior 3 years; 63.7% had allergic rhinitis, and 37.1% had asthma. Mean (SD) total medical cost of surgery was $14,697 (11,679) and mean (SD) 10-day total medical cost was $15,401 (11,968). Major complications occurred in 102 (1.7%) patients. Total medical costs and 10-day costs were higher in patients with major complications than those without ($23,605 [19,264] vs $15,251 [11,741]). Conclusion: In this descriptive analysis, NP surgery costs and rates of major surgical complications were updated using recent real-world data in the US. Results indicated that NP surgery complication rates were numerically higher than previously reported.
引用
收藏
页码:691 / 697
页数:7
相关论文
共 50 条
  • [1] Real-World Cost of Nasal Polyps Surgery and Risk of Major Complications in the United States: A Descriptive Retrospective Database Analysis (vol 14, page 691, 2022)
    Ge, W.
    Wang, D.
    Chuang, C. C.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2023, 15 : 209 - 211
  • [2] A REAL-WORLD CLAIMS ANALYSIS OF GLIOBLASTOMA COST OF CARE IN THE UNITED STATES
    Norden, A.
    You, M.
    Dastani, H.
    Bobiak, S.
    Korytowsky, B.
    Singh, P.
    VALUE IN HEALTH, 2017, 20 (05) : A360 - A360
  • [3] Real-World Effectiveness of Systemic Therapies for Atopic Dermatitis (AD) in the United States: Analysis of a Retrospective Claims Database
    DiBonaventura, Marco
    Lafeuille, Marie-Helene
    Emond, Bruno
    Duh, Mei Sheng
    Fakih, Iman
    Yin, Natalie
    Myers, Daniela
    Feeney, Claire
    Cappelleri, Joseph
    Wu, Jashin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB31 - AB31
  • [4] Real-world characterisation of patients with chronic rhinosinusitis with nasal polyps with and without surgery in England
    Benson, Victoria S.
    Fu, Qinggong
    Yang, Shibing
    Sousa, Ana R.
    Chan, Robert H.
    Howarth, Peter
    Hopkins, Claire
    CLINICAL OTOLARYNGOLOGY, 2023, 48 (04) : 680 - 688
  • [5] REAL-WORLD PRESCRIBING PATTERNS FOR THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS IN THE UNITED STATES: A RETROSPECTIVE DATABASE ANALYSIS
    Sulham, K.
    Fan, W.
    Werner, R.
    VALUE IN HEALTH, 2015, 18 (03) : A247 - A247
  • [6] ECONOMIC BURDEN OF MAJOR COMPLICATIONS IN PATIENTS UNDERGOING LOWER ANTERIOR RESECTION SURGERY: A REAL-WORLD DATABASE STUDY
    Wei, D.
    Roy, S.
    Goldstein, L. J.
    Kalsekar, I
    VALUE IN HEALTH, 2017, 20 (05) : A184 - A184
  • [7] Tamsulosin dispensation patterns in the United States: a real-world, longitudinal, population claims database analysis
    Kava, Bruce R.
    Verbeek, Anna E.
    Wruck, Jan M.
    Gittelman, Marc
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 (04) : 329 - +
  • [8] Real-world use of difelikefalin in hemodialysis patients at a large dialysis organization in the United States: a retrospective database study
    Ficociello, Linda H.
    Lasky, Rachel
    Arens, Hans-Juergen
    Ruessmann, Despina
    Anger, Michael S.
    BMC NEPHROLOGY, 2025, 26 (01)
  • [9] Real-World Outcomes of Selective RET Inhibitor Selpercatinib in the United States: Descriptive, Retrospective Findings from Two Databases
    Liao, Chi-Yin
    Gonzalez-Ferrer, Carmen
    Whipple, Samuel
    Peterson, Patrick M.
    Barker, Scott S.
    Bhandari, Naleen Raj
    Wang, Feng
    CANCERS, 2024, 16 (22)
  • [10] Developing a real-world database for oncology: a descriptive analysis of breast cancer in Argentina
    Streich, Guillermo
    Blanco Villalba, Marcelo
    Cid, Christian
    Bramuglia, Guillermo F.
    ECANCERMEDICALSCIENCE, 2022, 16